Real-World watch: tracking a leukemia Drug's performance in korea
NCT ID NCT05189639
Summary
This study aims to monitor the safety and effectiveness of the drug Mylotarg in adults newly diagnosed with a type of blood cancer called acute myeloid leukemia (AML). It will observe 165 patients in Korea who are already receiving Mylotarg as part of their standard hospital care. Researchers will track any side effects and how well the drug works to control the cancer over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul national university hospital
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.